Sen. Elizabeth Warren (D-MA) (Jose Luis Magana/AP Images)
GSK and others delist Orange Book patents after FTC targets protections on inhalers and epinephrine injectors
Three pharma companies have agreed to delist some of the patents challenged by the Federal Trade Commission in November, part of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
